Nifty
Sensex
:
:
25377.55
82948.23
-41.00 (-0.16%)
-131.43 (-0.16%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 533543 | NSE: BROOKS

86.97
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  88.50
  •  88.50
  •  85.50
  •  86.29
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  17376
  •  15.08
  •  185.70
  •  73.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 403.28
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 407.63
  • N/A
  • 5.46

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 63.59%
  • 4.17%
  • 25.57%
  • FII
  • DII
  • Others
  • 0%
  • 3.86%
  • 2.81%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -4.20
  • 0.18
  • -6.47

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -7.02
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -11.17
  • 2.55

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.31
  • 3.36
  • 3.36

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.87
  • 8.02
  • 8.02

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Net Sales
17.93
15.70
14.20%
17.72
12.61
40.52%
21.75
15.30
42.16%
24.32
18.08
34.51%
Expenses
17.65
15.68
12.56%
17.34
12.73
36.21%
20.65
23.86
-13.45%
22.60
27.31
-17.25%
EBITDA
0.28
0.02
1,300.00%
0.38
-0.12
-
1.10
-8.55
-
1.72
-9.23
-
EBIDTM
1.57%
0.16%
2.14%
-0.95%
5.04%
-55.90%
7.06%
-51.03%
Other Income
0.07
0.06
16.67%
0.65
0.03
2,066.67%
0.16
0.09
77.78%
0.09
0.14
-35.71%
Interest
0.16
0.17
-5.88%
0.27
0.18
50.00%
0.21
0.75
-72.00%
0.19
0.63
-69.84%
Depreciation
0.40
0.44
-9.09%
0.46
0.43
6.98%
0.43
2.33
-81.55%
0.44
2.28
-80.70%
PBT
-0.21
-0.53
-
0.30
-0.71
-
0.60
-11.18
-
1.18
-12.00
-
Tax
0.00
0.00
0
0.00
0.00
0
0.03
-1.70
-
0.00
-3.85
-
PAT
-0.21
-0.53
-
0.30
-0.71
-
0.58
-9.48
-
1.18
-8.14
-
PATM
-1.18%
-3.39%
1.72%
-5.64%
2.65%
-61.98%
4.85%
-45.03%
EPS
-0.92
-1.79
-
-3.66
-1.72
-
-1.48
-2.01
-
-0.62
-1.88
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Mar 21
Net Sales
81.72
63.20
91.18
77.25
Net Sales Growth
32.47%
-30.69%
18.03%
 
Cost Of Goods Sold
57.95
50.60
62.79
47.57
Gross Profit
23.77
12.60
28.40
29.67
GP Margin
29.09%
19.94%
31.15%
38.41%
Total Expenditure
78.24
89.62
105.44
76.73
Power & Fuel Cost
-
3.23
3.99
2.70
% Of Sales
-
5.11%
4.38%
3.50%
Employee Cost
-
16.00
16.85
12.04
% Of Sales
-
25.32%
18.48%
15.59%
Manufacturing Exp.
-
7.85
9.53
5.44
% Of Sales
-
12.42%
10.45%
7.04%
General & Admin Exp.
-
4.07
6.37
4.19
% Of Sales
-
6.44%
6.99%
5.42%
Selling & Distn. Exp.
-
1.68
1.69
1.54
% Of Sales
-
2.66%
1.85%
1.99%
Miscellaneous Exp.
-
6.19
4.22
3.23
% Of Sales
-
9.79%
4.63%
4.18%
EBITDA
3.48
-26.42
-14.26
0.52
EBITDA Margin
4.26%
-41.80%
-15.64%
0.67%
Other Income
0.97
0.20
0.80
0.74
Interest
0.83
2.18
3.10
3.10
Depreciation
1.73
7.03
7.35
7.14
PBT
1.87
-35.42
-23.90
-8.99
Tax
0.03
-7.32
-4.59
10.38
Tax Rate
1.60%
20.88%
19.21%
-115.46%
PAT
1.85
-20.90
-11.29
-19.38
PAT before Minority Interest
1.85
-31.05
-19.31
-19.38
Minority Interest
0.00
10.15
8.02
0.00
PAT Margin
2.26%
-33.07%
-12.38%
-25.09%
PAT Growth
109.81%
-
-
 
EPS
0.71
-7.98
-4.31
-7.40

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Shareholder's Funds
73.95
87.49
79.15
Share Capital
24.70
24.70
24.70
Total Reserves
49.25
62.79
54.45
Non-Current Liabilities
2.62
11.36
19.31
Secured Loans
0.00
9.29
14.44
Unsecured Loans
0.00
0.00
0.00
Long Term Provisions
1.46
2.17
1.54
Current Liabilities
33.02
48.88
63.61
Trade Payables
23.37
28.00
30.95
Other Current Liabilities
2.67
8.80
17.89
Short Term Borrowings
5.66
11.05
13.64
Short Term Provisions
1.32
1.03
1.13
Total Liabilities
109.59
194.56
162.07
Net Block
15.01
110.01
107.56
Gross Block
43.79
142.81
133.42
Accumulated Depreciation
28.78
32.79
25.86
Non Current Assets
81.99
133.37
112.19
Capital Work in Progress
0.00
15.11
0.83
Non Current Investment
64.03
0.06
0.02
Long Term Loans & Adv.
2.79
7.97
3.48
Other Non Current Assets
0.17
0.22
0.31
Current Assets
27.61
61.18
47.36
Current Investments
0.00
0.00
0.00
Inventories
11.30
27.52
23.60
Sundry Debtors
12.75
17.66
13.70
Cash & Bank
1.08
3.81
1.70
Other Current Assets
2.48
1.55
0.65
Short Term Loans & Adv.
2.08
10.64
7.70
Net Current Assets
-5.42
12.30
-16.25
Total Assets
109.60
194.55
159.55

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
-14.49
-37.44
4.46
PBT
-35.43
-23.90
-8.99
Adjustment
9.69
11.05
10.29
Changes in Working Capital
11.40
-24.33
7.37
Cash after chg. in Working capital
-14.34
-37.18
8.66
Interest Paid
0.00
0.00
0.00
Tax Paid
-0.15
-0.26
-4.20
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
0.49
-24.91
-5.13
Net Fixed Assets
-0.47
-2.53
Net Investments
-0.01
-0.03
Others
0.97
-22.35
Cash from Financing Activity
11.41
64.07
1.16
Net Cash Inflow / Outflow
-2.58
1.72
0.49
Opening Cash & Equivalents
2.61
0.88
0.40
Closing Cash & Equivalent
0.02
2.61
0.88

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
29.65
35.07
32.04
ROA
-20.42%
-10.83%
-11.95%
ROE
-38.47%
-23.18%
-24.48%
ROCE
-37.84%
-18.72%
-5.33%
Fixed Asset Turnover
0.68
0.66
0.58
Receivable days
87.83
62.77
64.72
Inventory Days
112.11
102.32
111.53
Payable days
185.27
171.35
237.48
Cash Conversion Cycle
14.66
-6.26
-61.23
Total Debt/Equity
0.08
0.28
0.40
Interest Cover
-16.58
-6.72
-1.90

News Update:


  • Brooks Laboratories - Quarterly Results
    14th Aug 2024, 17:42 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.